Surgical oncologist Ajay Jain, M.D., has established his practice with the Stephenson Cancer Center at OU Medicine.
People with prediabetes or other risk factors for type 2 diabetes can reduce their risk of the disease by participating in the Harold Hamm Diabetes Center’s PreventT2 program.
OU Medicine neurosurgeons are using a new medical device to prevent aneurysm rupture and recurrence
OU Medicine earned membership in the national HLHS Consortium.
The Stephenson Cancer Center welcomes a new tobacco regulatory scientist, Amy Cohn, Ph.D., to join a growing team of researchers dedicated to reducing the burden of tobacco-related diseases and deaths in Oklahoma.
Dr Ralf Janknecht awarded a five-year, $1.78 million grant from the National Cancer Institute to further evaluate a particular molecule’s potential in reducing cancer metastasis.
For smokers who are trying to quit, what if a smartphone app could predict when they are most likely to relapse and light a cigarette? Such technology has been created at the Oklahoma Tobacco Research Center.
Lawrence Rothblum, Ph.D., a professor of cell biology at the University of Oklahoma College of Medicine, has been elected a fellow of the American Association for the Advancement of Science.